Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Resonate Blends, Inc. (TXHD)
|
Add to portfolio |
|
|
Price: |
$0.31
| | Metrics |
OS: |
81.7
|
M
| |
|
|
Market cap: |
$24.9
|
M
| |
|
|
Net debt:
|
$3.05
|
M
| |
|
|
EV:
|
$28
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($737.4)
|
k
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
Revenues | 0.0 | 0.2 | 0.0 | 1.1 | 0.9 | 0.5 | 0.1 | 0.3 |
Revenue growth | -86.2% | | -100.0% | 13.0% | 105.9% | 293.9% | -66.0% | 0.8% |
Cost of goods sold | 0.3 | 0.2 | 0.0 | 0.3 | 0.3 | 0.1 | 0.1 | 0.2 |
Gross profit | -0.2 | 0.0 | 0.0 | 0.8 | 0.6 | 0.4 | 0.0 | 0.2 |
Gross margin | -844.8% | 0.0% | | 70.5% | 66.4% | 77.5% | 0.0% | 55.1% |
Selling, general and administrative | | | | | | 1.2 | 3.2 | |
Sales and marketing | 0.6 | 0.0 | 0.0 | 0.1 | 0.0 | | | |
Research and development | | | | | | | | |
General and administrative | 0.7 | 1.2 | 0.3 | 0.4 | 0.7 | | | 0.4 |
EBIT | -2.5 | -1.8 | -3.3 | -0.3 | -6.5 | -0.9 | -3.0 | -0.2 |
EBIT margin | -9364.8% | -939.4% | | -28.8% | -693.9% | -198.7% | -2585.1% | -69.6% |
Pre-tax income | -4.9 | -2.0 | -3.5 | -0.3 | -7.6 | -3.3 | -3.6 | -0.5 |
Income taxes | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.8% | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Earnings from continuing ops | -4.9 | -2.0 | -3.5 | -0.3 | -7.6 | -3.3 | -3.6 | -0.5 |
Earnings from discontinued ops | | | -0.1 | | | | | |
Net income | -4.9 | -1.9 | -3.7 | -0.3 | -7.6 | -3.3 | -3.6 | -0.5 |
Net margin | -18027.7% | -987.9% | | -31.9% | -810.5% | -725.3% | -3055.3% | -133.4% |
|
Diluted EPS | ($0.16) | ($0.08) | ($0.31) | ($0.08) | ($3.83) | ($25.18) | ($0.04) | ($0.01) |
Shares outstanding (diluted) | 31.1 | 25.5 | 11.2 | 4.2 | 2.0 | 0.1 | 82.3 | 68.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|